{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["advanced hepatocellular carcinoma", "hand-foot skin reaction", "nursing intervention", "ozone oil", "sorafenib"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [{"AbstractText": ["\u5bf9\u6bd4\u533b\u7528\u81ed\u6c27\u6cb9\u548c\u5c3f\u7d20\u8f6f\u818f\u5728\u9884\u9632\u548c\u6cbb\u7597\u7d22\u62c9\u975e\u5c3c\u6cbb\u7597\u809d\u7ec6\u80de\u764c(HCC)\u6240\u5bfc\u81f4\u624b\u8db3\u76ae\u80a4\u53cd\u5e94(HFSR)\u7684\u6548\u679c\u3002", "\u4e8e2018\u5e744\u6708~2020\u5e741\u6708\u5171\u5165\u7ec499\u4f8b\u4f9d\u636e\u7f8e\u56fd\u56fd\u5bb6\u7efc\u5408\u764c\u75c7\u7f51(NCCN)\u6307\u5357\u8bca\u65ad\u6807\u51c6\u786e\u8bca\u4e3a\u665a\u671f\u539f\u53d1\u6027\u809d\u764c\u5e76\u4e14\u9996\u6b21\u63a5\u53d7\u7d22\u62c9\u975e\u5c3c\u6cbb\u7597\u7684\u60a3\u8005\uff0c\u6309\u7167\u6570\u5b57\u968f\u673a\u65b9\u6cd5\u5206\u4e3a\u8bd5\u9a8c\u7ec4\u548c\u5bf9\u7167\u7ec4\uff0c\u5176\u4e2d\u8bd5\u9a8c\u7ec4(\u533b\u7528\u81ed\u6c27\u6cb9\u7ec4)49\u4f8b\uff0c\u5bf9\u7167\u7ec4(\u5c3f\u7d20\u8f6f\u818f\u7ec4)50\u4f8b\u3002\u5728\u5f00\u59cb\u670d\u7528\u7d22\u62c9\u975e\u5c3c\u6cbb\u7597\u65f6\uff0c\u8bd5\u9a8c\u7ec4\u548c\u5bf9\u7167\u7ec4\u60a3\u8005\u5206\u522b\u7ed9\u4e88\u533b\u7528\u81ed\u6c27\u6cb9\u548c10%\u5c3f\u7d20\u8f6f\u818f\u5916\u6d82\uff0c\u5747\u5300\u6d82\u62b9\u624b\u638c\u548c\u8db3\u5e95\u76ae\u80a4\uff0c\u5305\u62ec\u6307\u7f1d\u3001\u5173\u8282\u5904\u3002\u8bd5\u9a8c\u7ec4\u91c7\u7528\u533b\u7528\u81ed\u6c27\u6cb9\u6d82\u62b9\u624b\u8db3\uff0c1 mL/\u6b21\uff0c3\u6b21/d; \u5bf9\u7167\u7ec4\u91c7\u752810%\u5c3f\u7d20\u8f6f\u818f\u6d82\u62b9\u624b\u8db3\uff0c2 g/\u6b21\uff0c3\u6b21/d\u3002\u4e24\u7ec4\u7686\u62a4\u7406\u5e72\u988412\u5468\uff0c\u968f\u8bbf14\u5468\uff0c\u6bcf2\u5468\u89c2\u5bdfHFSR\u53d1\u751f\u60c5\u51b5\u3002", "\u5728\u6392\u96648\u4f8b\u56e0\u4f9d\u4ece\u6027\u4e0d\u4f73\u6216\u65b9\u6848\u8fdd\u80cc\u7684\u60a3\u8005\u540e\uff0c\u5171\u8ba191\u4f8b\u88ab\u7eb3\u5165\u5206\u6790\uff0c\u5176\u4e2d\u8bd5\u9a8c\u7ec444\u4f8b\uff0c\u5bf9\u7167\u7ec447\u4f8b\u3002\u5728\u968f\u8bbf\u8fc7\u7a0b\u4e2d\uff0c\u8bd5\u9a8c\u7ec4\u7d2f\u79ef16\u4f8b(36.4%)\u53d1\u751fHFSR\uff0c\u663e\u8457\u4f4e\u4e8e\u5bf9\u7167\u7ec427\u4f8b(57.4%)\uff0c(<i>P</i> < 0.05);2/3\u7ea7HFSR\u536015.9%(7/44)\uff0c\u4f4e\u4e8e\u5bf9\u7167\u7ec427.7%(13/47)\u3002", "\u76f8\u8f83\u4e8e\u5c3f\u7d20\u8f6f\u818f\u7ec4\uff0c\u533b\u7528\u81ed\u6c27\u6cb9\u53ef\u663e\u8457\u964d\u4f4eHCC\u60a3\u8005\u4f7f\u7528\u7d22\u62c9\u975e\u5c3c\u6cbb\u7597\u65f6HFSR\u53d1\u751f\u7387\uff0c\u51cf\u8f7bHFSR\u4e25\u91cd\u7a0b\u5ea6\uff0c\u4ece\u800c\u6539\u5584\u7d22\u62c9\u975e\u5c3c\u6cbb\u7597\u60a3\u8005\u7684\u751f\u6d3b\u8d28\u91cf\uff0c\u63d0\u9ad8\u60a3\u8005\u7684\u6cbb\u7597\u4f9d\u4ece\u6027\u3002"]}], "GeneralNote": [], "PMID": "33118519", "DateCompleted": {"Year": "2020", "Month": "11", "Day": "02"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "04"}, "Article": {"Language": ["chi"], "ArticleDate": [], "ELocationID": ["10.12122/j.issn.1673-4254.2020.10.15"], "Journal": {"ISSN": "1673-4254", "JournalIssue": {"Volume": "40", "Issue": "10", "PubDate": {"Year": "2020", "Month": "Oct", "Day": "30"}}, "Title": "Nan fang yi ke da xue xue bao = Journal of Southern Medical University", "ISOAbbreviation": "Nan Fang Yi Ke Da Xue Xue Bao"}, "ArticleTitle": "[Effect of ozone oil for prevention and treatment of sorafenib-induced hand-foot skin reactions: a randomized controlled trial].", "Pagination": {"StartPage": "1488", "EndPage": "1492", "MedlinePgn": "1488-1492"}, "Abstract": {"AbstractText": ["To compare the effects of medical ozone oil and urea ointment for prevention and treatment of hand-foot skin reaction (HFSR) caused by sorafenib in patients with hepatocellular carcinoma (HCC).", "A total of 99 patients diagnosed with advanced HCC according to National Comprehensive Cancer Network (NCCN) who were scheduled to receive sorafenib treatment for the first time were enrolled in this study between April, 2018 and January, 2020. The patients were randomized into medical ozone oil group (<i>n</i>=49) and urea ointment group (control group, <i>n</i>=49) for treatment with local application of 1 mL medical ozone oil (experimental group) and 10% urea ointment (2 g) on the palm and plantar skin (including the fingers and joints) for 12 weeks (3 times per day) starting at the beginning of sorafenib treatment, respectively. The patients were observed for occurrence of HFSR every 2 weeks for 14 weeks.", "Eight patients were excluded for poor compliance or protocol violations, leaving a total of 91 patients for analysis, including 44 in medical ozone oil group and 47 in urea ointment group. Sixteen (36.4%) of patients in ozone oil group developed HFSR, a rate significantly lower than that in urea ointment group (57.4%; <i>P</i> < 0.05). The incidence of grade 2/3 HFSR was also lower in ozone oil group than in urea ointment group (15.9% [7/44] <i>vs</i> 27.7 [13/47]).", "Medical ozone oil can significantly reduce the incidence and severity of HFSR to improve the quality of life of HCC patients receiving sorafenib treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cancer Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China."}], "LastName": "Chen", "ForeName": "Xiaowei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cancer Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China."}], "LastName": "Jiang", "ForeName": "Yiyue", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cancer Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China."}], "LastName": "Zhang", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cancer Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China."}], "LastName": "Dai", "ForeName": "Wencong", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cancer Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China."}], "LastName": "Fan", "ForeName": "Rong", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Center, Hospital of Integrated Traditional and Western Medicine, Southern Medical University, Guangzhou 510310, China."}], "LastName": "Weng", "ForeName": "Xie", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cancer Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China."}], "LastName": "He", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Center, Hospital of Integrated Traditional and Western Medicine, Southern Medical University, Guangzhou 510310, China."}], "LastName": "Yan", "ForeName": "Feifei", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Liver Cancer Center, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China."}], "LastName": "Guo", "ForeName": "Yabing", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Nan Fang Yi Ke Da Xue Xue Bao", "NlmUniqueID": "101266132", "ISSNLinking": "1673-4254"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenylurea Compounds"}, {"RegistryNumber": "25X51I8RD4", "NameOfSubstance": "Niacinamide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9ZOQ3TZI87", "NameOfSubstance": "Sorafenib"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["drug therapy", "etiology", "prevention & control"], "DescriptorName": "Hand-Foot Syndrome"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Niacinamide"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Phenylurea Compounds"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Sorafenib"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "\u6731 \u5b8f\u658c. \u809d\u764c\u5206\u5b50\u9776\u5411\u6cbb\u7597\u76f8\u5173\u7814\u7a76\u8fdb\u5c55. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=yxyjsxb201907015. \u533b\u5b66\u7814\u7a76\u751f\u5b66\u62a5. 2019;32(7):744\u20139. [\u6731\u5b8f\u658c.\u809d\u764c\u5206\u5b50\u9776\u5411\u6cbb\u7597\u76f8\u5173\u7814\u7a76\u8fdb\u5c55[J].\u533b\u5b66\u7814\u7a76\u751f\u5b66\u62a5, 2019, 32(7): 744-9.]"}, {"Citation": "\u5b89 \u6f9c, \u66fe \u7ea2\u6885, \u90d1 \u8363\u5bff, et al.  2015\u5e74\u4e2d\u56fd\u809d\u764c\u6d41\u884c\u60c5\u51b5\u5206\u6790. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhzl201910002. \u4e2d\u534e\u80bf\u7624\u6742\u5fd7. 2019;41(10):721\u20137. [\u5b89\u6f9c, \u66fe\u7ea2\u6885, \u90d1\u8363\u5bff, \u7b49. 2015\u5e74\u4e2d\u56fd\u809d\u764c\u6d41\u884c\u60c5\u51b5\u5206\u6790[J].\u4e2d\u534e\u80bf\u7624\u6742\u5fd7, 2019, 41(10): 721-7.]", "ArticleIdList": ["0"]}, {"Citation": "\u8881 \u54cd\u6797. \u4e2d\u665a\u671f\u539f\u53d1\u6027\u809d\u764c\u7684\u964d\u671f\u8f6c\u5316\u6cbb\u7597. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lcgdbzz202002006. \u4e34\u5e8a\u809d\u80c6\u75c5\u6742\u5fd7. 2020;36(2):267\u201371. [\u8881\u54cd\u6797.\u4e2d\u665a\u671f\u539f\u53d1\u6027\u809d\u764c\u7684\u964d\u671f\u8f6c\u5316\u6cbb\u7597[J].\u4e34\u5e8a\u809d\u80c6\u75c5\u6742\u5fd7, 2020, 36(2): 267-71.]"}, {"Citation": "Ogasawara S, Kanai F, Obi S, et al. Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma. Hepatol Int. 2011;5:850\u20136. doi: 10.1007/s12072-010-9249-4. [Ogasawara S, Kanai F, Obi S, et al. Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma[J]. Hepatol Int, 2011, 5: 850-6.]", "ArticleIdList": ["10.1007/s12072-010-9249-4", "21484134"]}, {"Citation": "Kudo M, Imanaka K, Chida N, et al. Phase \u2162 study of sorafenib after transarterial chemoembolization in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer. 2011;47:2117\u201327. doi: 10.1016/j.ejca.2011.05.007. [Kudo M, Imanaka K, Chida N, et al. Phase \u2162 study of sorafenib after transarterial chemoembolization in Japanese and Korean patients with unresectable hepatocellular carcinoma[J]. Eur J Cancer, 2011, 47: 2117-27.]", "ArticleIdList": ["10.1016/j.ejca.2011.05.007", "21664811"]}, {"Citation": "\u5b89 \u6797\u9759, \u90dd \u4e3d\u71d5, \u5f20 \u6615, et al.  \u7d22\u62c9\u975e\u5c3c\u6cbb\u7597\u809d\u7ec6\u80de\u764c\u60a3\u8005\u7684\u4e0d\u826f\u53cd\u5e94\u53ca\u5176\u5bf9\u9884\u540e\u7684\u5f71\u54cd. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jfjhlzz201117003. \u89e3\u653e\u519b\u62a4\u7406\u6742\u5fd7. 2011;28(17):8\u201311. [\u5b89\u6797\u9759, \u90dd\u4e3d\u71d5, \u5f20\u6615, \u7b49.\u7d22\u62c9\u975e\u5c3c\u6cbb\u7597\u809d\u7ec6\u80de\u764c\u60a3\u8005\u7684\u4e0d\u826f\u53cd\u5e94\u53ca\u5176\u5bf9\u9884\u540e\u7684\u5f71\u54cd[J].\u89e3\u653e\u519b\u62a4\u7406\u6742\u5fd7, 2011, 28(17): 8-11.]"}, {"Citation": "\u4f55 \u6653\u5cf0. \u81ed\u6c27\u6cbb\u7597\u7684\u4e34\u5e8a\u5e94\u7528. \u5317\u4eac: \u79d1\u5b66\u51fa\u7248\u793e; 2009. [\u4f55\u6653\u5cf0.\u81ed\u6c27\u6cbb\u7597\u7684\u4e34\u5e8a\u5e94\u7528[M].\u5317\u4eac:\u79d1\u5b66\u51fa\u7248\u793e, 2009.]"}, {"Citation": "\u987e \u741b, \u59dc \u5efa\u5a01, \u5434 \u6e05\u534e, et al.  \u81ed\u6c27\u6c14\u6d74\u6cbb\u7597\u7cd6\u5c3f\u75c5\u611f\u67d3\u6027\u8db3\u6e83\u75a1\u4e34\u5e8a\u89c2\u5bdf. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jsdxxb-yxb200903023. \u6c5f\u82cf\u5927\u5b66\u5b66\u62a5(\u533b\u5b66\u7248) 2009;19(3):270\u20131. [\u987e\u741b, \u59dc\u5efa\u5a01, \u5434\u6e05\u534e, \u7b49.\u81ed\u6c27\u6c14\u6d74\u6cbb\u7597\u7cd6\u5c3f\u75c5\u611f\u67d3\u6027\u8db3\u6e83\u75a1\u4e34\u5e8a\u89c2\u5bdf[J].\u6c5f\u82cf\u5927\u5b66\u5b66\u62a5(\u533b\u5b66\u7248), 2009, 19(3): 270-1.]"}, {"Citation": "\u90ed \u4e9a\u5175, \u5468 \u798f\u5143, \u5f6d \u52bc. \u533b\u7528\u4e09\u6c27\u4e34\u5e8a\u5e94\u7528\u57fa\u7840\u53ca\u5176\u5728\u809d\u708e\u7b49\u75be\u75c5\u6cbb\u7597\u4e2d\u7684\u521d\u6b65\u5b9e\u8df5. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jslcyxzz200701002. \u5b9e\u7528\u4e34\u5e8a\u533b\u836f\u6742\u5fd7. 2007;11(1):4\u20138. [\u90ed\u4e9a\u5175, \u5468\u798f\u5143, \u5f6d\u52bc.\u533b\u7528\u4e09\u6c27\u4e34\u5e8a\u5e94\u7528\u57fa\u7840\u53ca\u5176\u5728\u809d\u708e\u7b49\u75be\u75c5\u6cbb\u7597\u4e2d\u7684\u521d\u6b65\u5b9e\u8df5[J].\u5b9e\u7528\u4e34\u5e8a\u533b\u836f\u6742\u5fd7, 2007, 11(1): 4-8.]"}, {"Citation": "\u674e \u4f1a\u829d, \u5218 \u4e66\u7530. \u4e09\u6c27\u8054\u5408\u836f\u7269\u6cbb\u7597\u6162\u6027\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u7597\u6548\u89c2\u5bdf. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyyy200916125. \u4e2d\u56fd\u5b9e\u7528\u533b\u836f. 2009;4(16):174\u20135. [\u674e\u4f1a\u829d, \u5218\u4e66\u7530.\u4e09\u6c27\u8054\u5408\u836f\u7269\u6cbb\u7597\u6162\u6027\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u7597\u6548\u89c2\u5bdf[J].\u4e2d\u56fd\u5b9e\u7528\u533b\u836f, 2009, 4(16): 174-5.]"}, {"Citation": "\u51cc \u829d\u96c4, \u6768 \u5b50\u53d1, \u674e \u7231\u598d. \u81ed\u6c27\u6cbb\u7597\u771f\u83cc\u6027\u76ae\u80a4\u75c5\u7684\u6548\u679c\u89c2\u5bdf. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=gdyxyxb200704034. \u5e7f\u4e1c\u533b\u5b66\u9662\u5b66\u62a5. 2007;4:437\u20138. [\u51cc\u829d\u96c4, \u6768\u5b50\u53d1, \u674e\u7231\u598d.\u81ed\u6c27\u6cbb\u7597\u771f\u83cc\u6027\u76ae\u80a4\u75c5\u7684\u6548\u679c\u89c2\u5bdf[J].\u5e7f\u4e1c\u533b\u5b66\u9662\u5b66\u62a5, 2007, 4: 437-8.]"}, {"Citation": "\u5218 \u5b81\u5b81, \u5f20 \u6539\u8fde, \u5f20 \u8389\u82b8, et al.  \u533b\u7528\u81ed\u6c27\u6cbb\u7597\u708e\u6027\u5173\u8282\u75c5\u7684\u7814\u7a76\u8fdb\u5c55. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgywylc201606023. \u4e2d\u56fd\u836f\u7269\u4e0e\u4e34\u5e8a. 2016;16(6):830\u20132. [\u5218\u5b81\u5b81, \u5f20\u6539\u8fde, \u5f20\u8389\u82b8, \u7b49.\u533b\u7528\u81ed\u6c27\u6cbb\u7597\u708e\u6027\u5173\u8282\u75c5\u7684\u7814\u7a76\u8fdb\u5c55[J].\u4e2d\u56fd\u836f\u7269\u4e0e\u4e34\u5e8a, 2016, 16(6): 830-2.]"}, {"Citation": "\u5b8b \u5b66\u5c90, \u5218 \u6d77\u9752. \u81ed\u6c27\u6cbb\u7597\u8170\u690e\u95f4\u76d8\u7a81\u51fa\u5408\u5e76\u690e\u7ba1\u72ed\u7a84\u75c7100\u4f8b. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xdkf2014z1020. \u4e2d\u56fd\u7ec4\u7ec7\u5de5\u7a0b\u7814\u7a76. 2014;18(B05):26. [\u5b8b\u5b66\u5c90, \u5218\u6d77\u9752.\u81ed\u6c27\u6cbb\u7597\u8170\u690e\u95f4\u76d8\u7a81\u51fa\u5408\u5e76\u690e\u7ba1\u72ed\u7a84\u75c7100\u4f8b[J].\u4e2d\u56fd\u7ec4\u7ec7\u5de5\u7a0b\u7814\u7a76, 2014, 18(B05): 26.]"}, {"Citation": "\u738b \u9e4f, \u5510 \u660e\u5a1c, \u845b \u7acb\u5b8f. \u81ed\u6c27\u5728\u53e3\u8154\u533b\u5b66\u5e94\u7528\u65b0\u8fdb\u5c55. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=bjkqyx201206017. \u5317\u4eac\u53e3\u8154\u533b\u5b66. 2012;20(6):351\u20133. [\u738b\u9e4f, \u5510\u660e\u5a1c, \u845b\u7acb\u5b8f.\u81ed\u6c27\u5728\u53e3\u8154\u533b\u5b66\u5e94\u7528\u65b0\u8fdb\u5c55[J].\u5317\u4eac\u53e3\u8154\u533b\u5b66, 2012, 20(6): 351-3.]"}, {"Citation": "\u9676 \u6625\u971e, \u718a \u6625\u71d5, \u738b \u6653\u541b, et al.  \u81ed\u6c27\u6cbb\u7597\u5e94\u7528\u4e8e\u5987\u79d1\u751f\u6b96\u9053\u708e\u75c7\u7684\u7597\u6548\u89c2\u5bdf. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jxyy201712038. \u6c5f\u897f\u533b\u836f. 2017;52(12):1357\u20138. [\u9676\u6625\u971e, \u718a\u6625\u71d5, \u738b\u6653\u541b, \u7b49.\u81ed\u6c27\u6cbb\u7597\u5e94\u7528\u4e8e\u5987\u79d1\u751f\u6b96\u9053\u708e\u75c7\u7684\u7597\u6548\u89c2\u5bdf[J].\u6c5f\u897f\u533b\u836f, 2017, 52(12): 1357-8.]", "ArticleIdList": ["0"]}, {"Citation": "\u7eb3 \u731b, \u674e \u971e, \u949f \u5e86\u5764. \u81ed\u6c27\u6cb9\u5728\u5c16\u9510\u6e7f\u75a3\u6fc0\u5149\u6cbb\u7597\u672f\u540e\u7684\u5e94\u7528. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=pfbyxb201806030. \u76ae\u80a4\u75c5\u4e0e\u6027\u75c5. 2018;40(6):831\u20132. [\u7eb3\u731b, \u674e\u971e, \u949f\u5e86\u5764.\u81ed\u6c27\u6cb9\u5728\u5c16\u9510\u6e7f\u75a3\u6fc0\u5149\u6cbb\u7597\u672f\u540e\u7684\u5e94\u7528[J].\u76ae\u80a4\u75c5\u4e0e\u6027\u75c5, 2018, 40(6): 831-2.]", "ArticleIdList": ["0"]}, {"Citation": "\u9c81 \u5efa\u4e91, \u90ed \u654f, \u9ece\u8d35 \u9e3f\u53d1, et al.  \u81ed\u6c27\u6c34\u8054\u5408\u81ed\u6c27\u6cb9\u6cbb\u7597\u8db3\u7663\u7684\u7597\u6548. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=hnykdx201802006. \u4e2d\u5357\u5927\u5b66\u5b66\u62a5:\u533b\u5b66\u7248. 2018;43(2):147\u201351. [\u9c81\u5efa\u4e91, \u90ed\u654f, \u9ece\u8d35\u9e3f\u53d1, \u7b49.\u81ed\u6c27\u6c34\u8054\u5408\u81ed\u6c27\u6cb9\u6cbb\u7597\u8db3\u7663\u7684\u7597\u6548[J].\u4e2d\u5357\u5927\u5b66\u5b66\u62a5:\u533b\u5b66\u7248, 2018, 43(2): 147-51.]", "ArticleIdList": ["29559597"]}, {"Citation": "\u96f7 \u6bc5, \u8463 \u5c0f\u5cf0, \u5218 \u8f89, et al.  \u4e00\u79cd\u81ed\u6c27\u6cb9\u7684\u6740\u83cc\u6548\u679c\u53ca\u6bd2\u6027\u8bd5\u9a8c\u89c2\u5bdf. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgxdxzz201810002. \u4e2d\u56fd\u6d88\u6bd2\u5b66\u6742\u5fd7. 2018;35(10):725\u20137. [\u96f7\u6bc5, \u8463\u5c0f\u5cf0, \u5218\u8f89, \u7b49.\u4e00\u79cd\u81ed\u6c27\u6cb9\u7684\u6740\u83cc\u6548\u679c\u53ca\u6bd2\u6027\u8bd5\u9a8c\u89c2\u5bdf[J].\u4e2d\u56fd\u6d88\u6bd2\u5b66\u6742\u5fd7, 2018, 35(10): 725-7.]"}, {"Citation": "Bocci V, Zanardia I, Valacchi G, et al. Validity of oxygen-ozone therapy as integrated medication form in chronic inflammatory diseases. Cardiovasc Hematol Disord Drug Targets. 2015;15:127\u201338. doi: 10.2174/1871529X1502151209114642. [Bocci V, Zanardia I, Valacchi G, et al. Validity of oxygen-ozone therapy as integrated medication form in chronic inflammatory diseases[J]. Cardiovasc Hematol Disord Drug Targets, 2015, 15: 127-38.]", "ArticleIdList": ["10.2174/1871529X1502151209114642", "26126818"]}, {"Citation": "Giombini A, Menotti F, di Cesare A, et al.  Comparison between intrarticular injection of hyaluronic acid, oxygen ozone, and the combination of both in the treatment of knee osteoarthrosis. http://www.ncbi.nlm.nih.gov/pubmed/27358159. J Biol Regul Homeost Agents. 2016;30(2):621\u20135. [Giombini A, Menotti F, di Cesare A, et al. Comparison between intrarticular injection of hyaluronic acid, oxygen ozone, and the combination of both in the treatment of knee osteoarthrosis[J]. J Biol Regul Homeost Agents, 2016, 30(2): 621-5.]", "ArticleIdList": ["27358159"]}, {"Citation": "Liu J, Zhang P, Tian J, et al.  Phototherapy for treating foot ulcers in people with diabetes. http://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011979.pub2/media/CDSR/CD011979/CD011979_abstract.pdf. Cochrane Database Syst Rev. 2015;6(10):CD011979. [Liu J, Zhang P, Tian J, et al. Phototherapy for treating foot ulcers in people with diabetes[J]. Cochrane Database Syst Rev, 2015, 6(10): CD011979.]", "ArticleIdList": ["PMC6481843", "28657134"]}, {"Citation": "Splendiani A, Perri M, Conchiglia A, et al.  MR assessment of lumbar disk herniation treated with oxygen-ozone diskolysis: the role of DWI and related ADC versus intervertebral disk volumetric analysis for detecting treatment response. http://europepmc.org/abstract/MED/23859294. Rivista Di Neuroradiol. 2013;26(3):347\u201356. [Splendiani A, Perri M, Conchiglia A, et al. MR assessment of lumbar disk herniation treated with oxygen-ozone diskolysis: the role of DWI and related ADC versus intervertebral disk volumetric analysis for detecting treatment response[J]. Rivista Di Neuroradiol, 2013, 26(3): 347-56.]", "ArticleIdList": ["PMC5278852", "23859294"]}, {"Citation": "Velikaya VV, Gribova OV, Musabaeva L, et al.  Ozone therapy for radiation reactions and skin lesions after neutron therapy in patients with malignant tumors. http://www.ncbi.nlm.nih.gov/pubmed/26571824. Voprosy Onkologii. 2015;61(4):571\u20134. [Velikaya VV, Gribova OV, Musabaeva L, et al. Ozone therapy for radiation reactions and skin lesions after neutron therapy in patients with malignant tumors[J]. Voprosy Onkologii, 2015, 61(4): 571-4.]", "ArticleIdList": ["26571824"]}, {"Citation": "\u8c22 \u9f0e\u826f, \u9ece \u98de\u731b, \u59da \u4f20\u9f99, et al.  \u533b\u7528\u81ed\u6c27\u6cbb\u7597\u2161\u7c7b\u4f24\u53e390\u4f8b\u4e34\u5e8a\u7597\u6548\u89c2\u5bdf. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xdyyws201404031. \u73b0\u4ee3\u533b\u836f\u536b\u751f. 2014;30(4):553\u20134. [\u8c22\u9f0e\u826f, \u9ece\u98de\u731b, \u59da\u4f20\u9f99, \u7b49.\u533b\u7528\u81ed\u6c27\u6cbb\u7597\u2161\u7c7b\u4f24\u53e390\u4f8b\u4e34\u5e8a\u7597\u6548\u89c2\u5bdf[J].\u73b0\u4ee3\u533b\u836f\u536b\u751f, 2014, 30(4): 553-4.]"}, {"Citation": "\u5a04 \u5c0f\u5a25, \u9648 \u654f, \u6768 \u6ce2. \u5206\u5b50\u9776\u5411\u6297\u80bf\u7624\u836f\u7269\u7684\u6bd2\u6027\u7814\u7a76\u8fdb\u5c55. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zjdxxb-yxb201505001. \u6d59\u6c5f\u5927\u5b66\u5b66\u62a5:\u533b\u5b66\u7248. 2015;44(5):473\u20138. [\u5a04\u5c0f\u5a25, \u9648\u654f, \u6768\u6ce2.\u5206\u5b50\u9776\u5411\u6297\u80bf\u7624\u836f\u7269\u7684\u6bd2\u6027\u7814\u7a76\u8fdb\u5c55[J].\u6d59\u6c5f\u5927\u5b66\u5b66\u62a5:\u533b\u5b66\u7248, 2015, 44(5): 473-8.]", "ArticleIdList": ["PMC10396823", "26713519"]}, {"Citation": "\u590f \u9759\u5a34, \u80e1 \u4e1c\u8273, \u738b \u5f3a. \u7d22\u62c9\u83f2\u5c3c\u6240\u81f4\u76ae\u80a4\u4e0d\u826f\u53cd\u5e94\u7684\u7814\u7a76\u8fdb\u5c55. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=shykdxxb201904021. \u590d\u65e6\u5b66\u62a5:\u533b\u5b66\u7248. 2019;46(4):551\u20135, 561. [\u590f\u9759\u5a34, \u80e1\u4e1c\u8273, \u738b\u5f3a.\u7d22\u62c9\u83f2\u5c3c\u6240\u81f4\u76ae\u80a4\u4e0d\u826f\u53cd\u5e94\u7684\u7814\u7a76\u8fdb\u5c55[J].\u590d\u65e6\u5b66\u62a5:\u533b\u5b66\u7248, 2019, 46(4): 551-5, 561.]"}, {"Citation": "Ren ZG, Zhu KS, Kang HY, et al. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2015;33(8):894\u2013900. doi: 10.1200/JCO.2013.52.9651. [Ren ZG, Zhu KS, Kang HY, et al. Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma[J]. J Clin Oncol, 2015, 33(8): 894-900.]", "ArticleIdList": ["10.1200/JCO.2013.52.9651", "25667293"]}, {"Citation": "\u5b89 \u6797\u9759, \u5f20 \u6615, \u5f20 \u4e3d\u5a1c, et al.  \u5c3f\u7d20\u4e73\u818f\u62a4\u7406\u5e72\u9884\u7d22\u62c9\u975e\u5c3c\u76f8\u5173\u624b\u8db3\u76ae\u80a4\u53cd\u5e94\u968f\u673a\u5bf9\u7167\u7814\u7a76. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=jslcyxzz201422014. \u5b9e\u7528\u4e34\u5e8a\u533b\u836f\u6742\u5fd7. 2014;18(22):45\u20137, 54. [\u5b89\u6797\u9759, \u5f20\u6615, \u5f20\u4e3d\u5a1c, \u7b49.\u5c3f\u7d20\u4e73\u818f\u62a4\u7406\u5e72\u9884\u7d22\u62c9\u975e\u5c3c\u76f8\u5173\u624b\u8db3\u76ae\u80a4\u53cd\u5e94\u968f\u673a\u5bf9\u7167\u7814\u7a76[J].\u5b9e\u7528\u4e34\u5e8a\u533b\u836f\u6742\u5fd7, 2014, 18(22): 45-7, 54.]"}, {"Citation": "Sharma M, Hudson JB. Ozone gas is an effective and practical antibacterial agent. Am J Infect Control. 2008;36(8):559\u201363. doi: 10.1016/j.ajic.2007.10.021. [Sharma M, Hudson JB. Ozone gas is an effective and practical antibacterial agent[J]. Am J Infect Control, 2008, 36(8): 559-63.]", "ArticleIdList": ["10.1016/j.ajic.2007.10.021", "18926308"]}, {"Citation": "\u859b \u5c71. \u533b\u7528\u81ed\u6c27\u4e34\u5e8a\u5e94\u7528\u73b0\u72b6\u7efc\u8ff0. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lcwzwz201102055. \u4e34\u5e8a\u8bef\u8bca\u8bef\u6cbb. 2011;24(2):80\u20132. [\u859b\u5c71.\u533b\u7528\u81ed\u6c27\u4e34\u5e8a\u5e94\u7528\u73b0\u72b6\u7efc\u8ff0[J].\u4e34\u5e8a\u8bef\u8bca\u8bef\u6cbb, 2011, 24(2): 80-2.]"}, {"Citation": "\u90ed \u4e9a\u5175, \u738b \u5764\u8fdc. \u533b\u7528\u81ed\u6c27\u53ca\u5176\u5728\u809d\u708e\u6cbb\u7597\u5b9e\u8df5\u5341\u5e74\u56de\u987e. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhlcyszz201519003. \u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7:\u7535\u5b50\u7248. 2015;9(19):10\u20133. [\u90ed\u4e9a\u5175, \u738b\u5764\u8fdc.\u533b\u7528\u81ed\u6c27\u53ca\u5176\u5728\u809d\u708e\u6cbb\u7597\u5b9e\u8df5\u5341\u5e74\u56de\u987e[J].\u4e2d\u534e\u4e34\u5e8a\u533b\u5e08\u6742\u5fd7:\u7535\u5b50\u7248, 2015, 9(19): 10-3.]"}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "29", "Hour": "8", "Minute": "39"}, {"Year": "2020", "Month": "10", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "11", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33118519", "PMC7606236", "10.12122/j.issn.1673-4254.2020.10.15"]}}], "PubmedBookArticle": []}